Volume 24, Issue 3 pp. 174-180
Original Article

Detection of malignant effusions: Comparison of a telomerase assay and cytologic examination

Richard Braunschweig M.D.

Corresponding Author

Richard Braunschweig M.D.

Institut de Pathologie, Centre Hospitalier Universitaire Vaudois, Lausanne

Institut de Pathologie, Centre Hospitalier Universitaire Vaudois, Bugnon 25, CH-1011 Lausanne, SwitzerlandSearch for more papers by this author
Pu Yan M.D.

Pu Yan M.D.

Institut de Pathologie, Centre Hospitalier Universitaire Vaudois, Lausanne

Search for more papers by this author
Isabelle Guilleret M.Sc.

Isabelle Guilleret M.Sc.

Institut de Pathologie, Centre Hospitalier Universitaire Vaudois, Lausanne

Search for more papers by this author
Françoise Delacretaz M.D.

Françoise Delacretaz M.D.

Institut de Pathologie, Centre Hospitalier Universitaire Vaudois, Lausanne

Search for more papers by this author
Fred T. Bosman M.D., Ph.D.

Fred T. Bosman M.D., Ph.D.

Institut de Pathologie, Centre Hospitalier Universitaire Vaudois, Lausanne

Search for more papers by this author
Anca Mihaescu M.D.

Anca Mihaescu M.D.

Institut de Pathologie, Centre Hospitalier Universitaire Vaudois, Lausanne

Search for more papers by this author
Jean Benhattar Ph.D.

Jean Benhattar Ph.D.

Institut de Pathologie, Centre Hospitalier Universitaire Vaudois, Lausanne

Search for more papers by this author

Abstract

Telomerase is inactive in most somatic cells, but has been found to be reactivated in a majority of cancers. Our principal goal was to test whether the presence of telomerase activity concurred with positive cytology, and was thus of potential use in detecting cancer cells in effusions. The telomeric repeat amplification protocol (TRAP) assay and cytological examination were performed in a blinded fashion on 91 unselected effusions, for which laboratory processing was done according to standard procedures. In our series, 30% (27/91) of samples were found to be malignant by cytology. Of these, 19 (70%) were also positive in the TRAP assay. Of the 8 telomerase-negative cytology-positive samples, RNA integrity was generally poor, indicating suboptimal sample conservation for molecular analysis. Negative cytology in the presence of telomerase activity was observed in 17 effusions. Of these, 11 were from patients with advanced cancer, and thus a diagnosis of malignant effusion should be suspected. The TRAP assay for telomerase activity holds promise in the analysis of effusions, but its routine use as an adjunct to cytology awaits further confirmation of its positive predictive value. Diagn. Cytopathol. 2001;24:174–180. © 2001 Wiley-Liss, Inc.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.